NabilaNora(Baiti)BennaniMD

PubMed

• 6 citations
  Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T-cell therapy recipients.
  Marissa Z Powell, Kristin C Mara, Radhika Bansal, Matthew A Hathcock, Arushi Khurana, N Nora Bennani, Yucai Wang, Jonas Paludo, Jose Villasboas Bisneto, Stephen M Anse...> ;Cancer Medicine. 2023 Apr 1
• 2 citations
  Pre-lymphodepletion & infusion endothelial activation and stress index as predictors of clinical outcomes in CAR-T therapy for B-cell lymphoma.
  Aldo A Acosta-Medina, Isla McKerrow Johnson, Radhika Bansal, Matthew Hathcock, Saad J Kenderian, Urshila Durani, Arushi Khurana, Yucai Wang, Jonas Paludo, Jose C Villa...> ;Blood Cancer Journal. 2023 Jan 5
• 6 citations
  Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma.
  Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley J Stish, Allison Rosenthal, Javier Munoz, Yi Lin, Radhika Bansal, Matthew A Hathcock, N Nora Benn...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Aug 1
• 1 citations
  Sirolimus as frontline therapy for-mutated histiocytic sarcoma.
  Karan L Chohan, Jithma P Abeykoon, Jason R Young, W Oliver Tobin, Mathew J Koster, Mithun V Shah, Jay H Ryu, Robert Vassallo, Karen L Rech, Aishwarya Ravindran, Gaurav...> ;Haematologica. 2023 Jun 1
• 1 citations
  High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course.
  Darragh F O'Donoghue, Huong L Truong, Heidi D Finnes, Jennifer S McDonald, Heather P May, Stephen M Ansell, N Nora Bennani, Thomas M Habermann, David J Inwards, Patric...> ;JCO Oncology Practice. 2022 Dec 1
• 13 citations
  Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status.
  Jithma P Abeykoon, Karen L Rech, Jason R Young, Aishwarya Ravindran, Gordon J Ruan, Surendra Dasari, Diana M Morlote, Rebecca L King, Claire Rummage, Saurabh Zanwar, A...> ;JAMA Oncology. 2022 Dec 1
• 4 citations
  Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findings.
  Antonious Z Hazim, Aldo A Acosta-Medina, Jason R Young, Gordon J Ruan, Jithma P Abeykoon, Aishwarya Ravindran, Robert Vassallo, Jay H Ryu, W Oliver Tobin, Matthew J Ko...> ;British Journal of Haematology. 2022 Nov 1
• 3 citations
  Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.
  Samantha A Banks, M Tariq Bhatti, Ronald S Go, Jithma P Abeykoon, Aldo A Acosta-Medina, Antonious Z Hazim, Gaurav Goyal, Jason R Young, Matthew J Koster, Robert Vassal...> ;Ophthalmology. 2023 Jan 1
• 17 citations
  Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant.
  Surbhi Sidana, Amylou C Dueck, Gita Thanarajasingam, Joan M Griffin, Carrie Thompson, Urshila Durani, Michelle Burtis, Rahma Warsame, Jonas Paludo, Morie A Gertz, Ange...> ;Transplantation and Cellular Therapy. 2022 Aug 1
• 9 citations
  Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy.
  Naba Farooqui, Janina Paula T Sy-Go, Jing Miao, Ramila Mehta, Lisa E Vaughan, N Nora Bennani, Yucai Wang, Radhika Bansal, Matthew A Hathcock, Suzanne R Hayman, Patrick...> ;Mayo Clinic Proceedings. 2022 Jul 1
• 2 citations
  Peak absolute lymphocyte count after CAR-T infusion predicts clinical response in aggressive lymphoma.
  Radhika Bansal, Mattia Novo, Abdullah S Al Saleh, Anatilde Gonzalez Guerrico, Henan Zhang, Zuoyi Shao, Elham Babadi, Kodi E Martinez, Gabrielle A McCoy, Matthew A Hath...> ;American Journal of Hematology. 2022 Jul 1
• 5 citations
  Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
  Saurabh Zanwar, Jithma P Abeykoon, Surendra Dasari, Jason R Young, Aldo A Acosta-Medina, Karen L Rech, Jonathan Schwartz, Aaron Mangold, Allison Rosenthal, N Nora Benn...> ;Blood Cancer Journal. 2022 Jun 28
• 20 citations
  Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma.
  Joselle Cook, Kah-Whye Peng, Thomas E Witzig, Stephen M Broski, Jose C Villasboas, Jonas Paludo, Mrinal Patnaik, Vincent Rajkumar, Angela Dispenzieri, Nelson Leung, Fr...> ;Blood Advances. 2022 Jun 14
• 4 citations
  Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis.
  Marie Hu, Gaurav Goyal, Jithma P Abeykoon, Aldo A Acosta-Medina, Gordan J Ruan, Jason R Young, Aishwarya Ravindran, N Nora Bennani, Mithun V Shah, Robert Vassallo, Jay...> ;Blood Cancer Journal. 2022 Jun 3
• 3 citations
  Incidence of thrombosis in relapsed/refractory B-cell lymphoma treated with axicabtagene ciloleucel: Mayo Clinic experience.
  Megan Melody, Sangeetha Gandhi, Hollie Saunders, Zaid Abdel-Rahman, Jacquelyn Hastings, Paula Lengerke Diaz, Nicole Gannon, Tuan Truong, Matthew Hathcock, Arushi Khura...> ;Leukemia & Lymphoma. 2022 Jun 1
• 23 citations
  Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression.
  N Nora Bennani, Hyo Jin Kim, Levi D Pederson, Pamela J Atherton, Ivana N Micallef, Gita Thanarajasingam, Grzegorz S Nowakowski, Thomas Witzig, Andrew L Feldman, Stephe...> ;Journal for Immunotherapy of Cancer. 2022 Jun 1
• 1 citations
  Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
  N Nora Bennani, Aung M Tun, Kenneth R Carson, Jessica L Geiger, Lauren S Maeda, Kerry J Savage, Jim Rose, Lauren Pinter-Brown, Matthew A Lunning, Jeremy S Abramson, Na...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 May 1
• 4 citations
  Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
  Jacqui-Lyn Saw, M Hasib Sidiqi, Michael Ruff, Sara Hocker, Hassan Alkhateeb, Stephen M Ansell, N Nora Bennani, David Dingli, Suzanne R Hayman, Patrick B Johnston, Pras...> ;Blood Cancer Journal. 2022 Apr 13
• Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
  N Nora Bennani, Aung M Tun, Kenneth R Carson, Jessica L Geiger, Lauren S Maeda, Kerry J Savage, Jim Rose, Lauren Pinter-Brown, Matthew A Lunning, Jeremy S Abramson, Na...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Apr 1
• 14 citations
  Metabolic characteristics and prognostic differentiation of aggressive lymphoma using one-month post-CAR-T FDG PET/CT.
  William G Breen, Matthew A Hathcock, Jason R Young, Roman O Kowalchuk, Radhika Bansal, Arushi Khurana, N Nora Bennani, Jonas Paludo, Jose C Villasboas Bisneto, Yucai W...> ;Journal of Hematology & Oncology. 2022 Mar 26
• 2 citations
  Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience.
  Gaurav Goyal, Jason R Young, Jithma P Abeykoon, Mithun V Shah, N Nora Bennani, Julio C Sartori-Valinotti, Robert Vassallo, Jay H Ryu, W Oliver Tobin, Matthew J Koster,...> ;The Oncologist. 2022 Mar 4
• 8 citations
  Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease.
  Jithma P Abeykoon, Terra L Lasho, Surendra Dasari, Karen L Rech, Wasantha K Ranatunga, Michelle K Manske, Alexander Tischer, Aishwarya Ravindran, Jason R Young, Willia...> ;American Journal of Hematology. 2022 Mar 1
• 22 citations
  Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?
  Omran Saifi, William G Breen, Scott C Lester, William G Rule, Bradley Stish, Allison Rosenthal, Javier Munoz, Steven M Herchko, Hemant S Murthy, Yi Lin, Radhika Bansal...> ;Radiotherapy and Oncology. 2022 Jan 1
• 2 citations
  Mimics of Erdheim-Chester disease.
  Jithma P. Abeykoon, Aishwarya Ravindran, Karen L Rech, Jason R Young, W. Oliver Tobin, Mithun V. Shah, N Nora Bennani, Robert Vassallo, Jay H. Ryu, Matthew J. Koster, ...> ;British Journal of Haematology. 2021 Nov 20
• 7 citations
  Age defining immune effector cell associated neurotoxicity syndromes in aggressive large B cell lymphoma patients treated with axicabtagene ciloleucel.
  Kitsada Wudhikarn, Radhika Bansal, Arushi Khurana, Matthew A. Hathcock, Sherri A. Braksick, N. Nora Bennani, Jonas Paludo, Jose C. Villasboas, Yucai Wang, Patrick B. J...> ;American Journal of Hematology. 2021 Nov 1
• Join now to see all

Journal Articles

• Genetic Subtyping of Breast Implant-Associated Anaplastic Large Cell Lymphoma  
  Andrew L Feldman, Garry S Brody, Rhett P Ketterling, N Nora Bennani, Mark W Clemens, Ellen D McPhail, Christin A Harless, David S Viswanatha, Rong He, Blood

Abstracts/Posters

• Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
  Nora N Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clinical Features and Outcomes of Unifocal Adult Langerhans Cell Histiocytosis
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Molecular Alterations in Adult Histiocytic Neoplasms
  Nora N Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• ZUMA-11: A Phase 1/2 Multicenter Study of Axicabtagene Ciloleucel (Axi-Cel) + Utomilumab Patients with Refractory Large B Cell Lymphoma
  Nabila N. Bennani, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
• Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...
  N. Nora Bennani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018